Enodia Therapeutics, a privately-held French biotech developing small molecule therapies targeting a unique form of protein ...

Johnson & Johnson has announced its financial results for the first quarter of 2026.

US clinical-stage biotechnology company Beeline Medicines today announced its official debut with the mission of developing ...

German drug discovery company Evotec today announced the appointment of Dr Ingrid Müller as chief operating officer (COO).

Danish allergy immunotherapy specialist ALK Abello today announced that Health Canada has approved Neffy 2mg adrenaline ...

India’s Rubicon Research today announced the acquisition of an 85% equity ownership in Arinna Lifesciences from its current ...

USA-based Galera Therapeutics and Obsidian Therapeutics, a privately-held clinical-stage biopharmaceutical company harnessing ...

The US Food and Drug Administration (FDA) has determined that only a clinical trial—rather than a nonclinical or ...

French immunotherapy company OSE Immunotherapeutics (Euronext Paris: OSE) has provided a senior management update. All the ...

US anti-virals specialist Gilead Sciences announced that the US State Department, the US President’s Emergency Plan for AIDS ...

San Diego, USA-based biotech Neomorph has announced the closing of a $100 million Series B financing. The round was led by ...

Texan pre-clinical stage biotech CrossBridge Bio, a developer of dual-payload antibody-drug conjugates (ADCs), has announced ...